Alpha-Lipoic Acid and Carnosine Composition for Phantom Limb Syndrome
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for phantom limb syndrome, including phantom limb pain and sensation, are not fully effective in reducing symptoms and improving quality of life for amputees, with a lack of understanding of underlying mechanisms and variable treatment outcomes.
Innovation Solution
A composition comprising α-lipoic acid and carnosine, or their pharmaceutically acceptable derivatives, is administered to treat phantom limb syndrome, reducing both pain and sensation components with stabilization of results over time, and providing antioxidant and anti-glycan effects, often in combination with zinc-based compounds and vitamins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments (gabapentin, methadone, tricyclic anti-depressants) are used for phantom limb syndrome, then some pain relief may be achieved, but treatment outcomes are variable and not fully effective in reducing both pain and sensation components
Solution Approach 1:
The patent combines alpha-lipoic acid and carnosine into a single composition to treat phantom limb syndrome. This merging of two active ingredients with complementary mechanisms (alpha-lipoic acid for antioxidant/anti-glycan effects and carnosine for protein protection and pH buffering) aims to achieve more reliable and comprehensive symptom reduction than single-agent therapies, addressing both pain and sensation components more effectively
Solution Approach 2:
The treatment uses a composite formulation comprising alpha-lipoic acid and carnosine together, rather than single substances. This composite approach leverages the synergistic effects of multiple compounds to improve treatment reliability and effectiveness, targeting the complex pathophysiology of phantom limb syndrome through multi-mechanistic action
2Reliability
If conventional treatments are administered, then some symptom reduction may occur, but the underlying mechanisms are not understood and results are inconsistent
Solution Approach 1:
Rather than waiting for complete understanding of all underlying mechanisms before treatment, the patent employs alpha-lipoic acid and carnosine based on their known biochemical properties and observed efficacy. The treatment skips the need for complete mechanistic elucidation, using the compounds' established antioxidant, anti-glycan, and protein-protective effects to achieve consistent clinical results
Solution Approach 2:
The patent changes the biochemical parameters in the affected tissues by administering alpha-lipoic acid (which reduces oxidative stress and glycation) and carnosine (which protects proteins and buffers pH). These parameter changes in the biological system lead to consistent treatment outcomes without requiring complete understanding of all neural mechanisms involved in phantom limb syndrome
3Duration of action of stationary object
If long-term treatment is provided to stabilize results, then quality of life improves, but treatment duration and cost increase
Solution Approach 1:
The patent employs alpha-lipoic acid and carnosine to preliminarily address the underlying biochemical abnormalities (oxidative stress, glycation, protein damage) that contribute to phantom limb syndrome. By taking preliminary action on these root causes, the treatment achieves stable long-term results that improve quality of life, with the added benefit that these compounds have long half-lives and accumulate beneficial effects over time
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces phantom limb sensation and pain, improving quality of life by stabilizing treatment outcomes with minimal side effects and complementary benefits, particularly when formulated with specific weight ratios and incorporating zinc-based compounds and vitamins.
Implementation Method 1
The composition effectively reduces phantom limb sensation and pain, improving quality of life by stabilizing treatment outcomes with minimal side effects and complementary benefits, particularly when formulated with specific weight ratios and incorporating zinc-based compounds and vitamins
Implementation Method 2
The composition effectively reduces phantom limb sensation and pain, improving quality of life by stabilizing treatment outcomes with minimal side effects and complementary benefits, particularly when formulated with specific weight ratios and incorporating zinc-based compounds and vitamins
Data Source
AI summary
The present invention relates to a composition comprising an effective amount of α- lipoic and carnosine, or pharmaceutically acceptable derivatives thereof for treating the phantom limb syndrome. The present invention also relates to the use of such a composition for treating the phantom limb syndrome.